CTIS2022-502681-24-00进行中（未招募）1 期
64407564MMY1005
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase 1b Study of Subcutaneous Daratumumab Regimens in Combination with Bispecific T Cell Redirection Antibodies for the Treatment of Subjects with Multiple MyelomaMultiple myelomaCTIS2023-503468-17-00Janssen - Cilag International290
进行中（未招募）
1 期
A Multi-arm Phase 1b Study of Talquetamab With Other Anticancer Therapies in Participants with Multiple Myelomamultiple myelomaCTIS2023-503620-60-00Janssen - Cilag International182
进行中（未招募）
1 期
A Study to Learn How Different Amounts and Forms of the Study Intervention Called PF-07899895 are Tolerated and Act in the Body of Healthy Adultslcerative ColitisMedDRA version: 20.0Level: PTClassification code: 10009900Term: Colitis ulcerative Class: 100000004856CTIS2023-507354-32-00Pfizer Inc.45
进行中（未招募）
1 期
A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy ParticipantsCTIS2024-512841-17-00Merck Healthcare KGaA40
进行中（未招募）
1 期
INtra-tumor miCro dosIng in PatIents with advanced malignant mElanoma receiving aNti-PD1 Therapy. A pilot study.CTIS2023-510544-21-00Z Leuven4